SCHEMBL25545528

SCHEMBL25545528

COCCOc1ccc(-c2nc(Cl)sc2CC(C)C)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 3/20 0.43
AAK1 Q2M2I8 6/20 0.38
S1PR4 O95977 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PIK3CG P48736 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
DCK P27707 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 1/20 0.33
ALDH1A1 P00352 2/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25545990 0.98 FBP1 (0.42) FBP1AAK1S1PR4PIK3CDPIK3CA
SCHEMBL25545551 0.95 FBP1 (0.43) FBP1AAK1S1PR4ALDH1A1PTGS1
SCHEMBL25545566 0.91 FBP1 (0.43) FBP1PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL25545985 0.90 FBP1 (0.40) FBP1AAK1S1PR4DCKPTGS1
SCHEMBL25545988 0.90 FBP1 (0.43) FBP1AAK1S1PR4PTGS2HPGD
SCHEMBL25545547 0.89 AAK1 (0.36) FBP1AAK1S1PR4DCKHTR2C
SCHEMBL25545564 0.88 S1PR4 (0.35) AAK1S1PR4PIK3CDPIK3CAPIK3CB
SCHEMBL25545925 0.88 ALDH1A1 (0.42) FBP1AAK1ALDH1A1PTGS1PTGS2
SCHEMBL25183737 0.87 FBP1 (0.45) FBP1PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL25556402 0.86 PTGS1 (0.42) FBP1AAK1S1PR4PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 FBP1 735/4885AAK1 1064/4885S1PR4 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.